Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Liver Cancer
Volume -, Issue -, Pages 1-11
Publisher
S. Karger AG
Online
2023-10-17
DOI
10.1159/000533991
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohort
- (2023) Fabian Jost‐Brinkmann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The prognostic role of tumour progression and liver function at progression under immunotherapy for hepatocellular carcinoma
- (2023) Giuseppe Cabibbo et al. LIVER INTERNATIONAL
- Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study
- (2022) Antonio D’Alessio et al. HEPATOLOGY
- Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice
- (2022) Takaaki Tanaka et al. HEPATOLOGY RESEARCH
- Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers
- (2022) Vera Himmelsbach et al. Cancers
- Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
- (2022) Benedetta Stefanini et al. DIGESTIVE AND LIVER DISEASE
- Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
- (2022) Takuya Sho et al. Cancers
- Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook
- (2022) Ariel Jaffe et al. LIVER INTERNATIONAL
- Treatment patterns for hepatocellular carcinoma in patients with Child–Pugh class B and their impact on survival: A Korean nationwide registry study
- (2022) Dongsub Jeon et al. LIVER INTERNATIONAL
- Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
- (2022) Thomas Talbot et al. LIVER INTERNATIONAL
- Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis
- (2021) Jean-Frédéric Blanc et al. Hepatology International
- Pattern of macrovascular invasion in hepatocellular carcinoma
- (2021) Maria Guarino et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
- (2021) Masatoshi Kudo et al. JOURNAL OF HEPATOLOGY
- Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting
- (2021) Maria Corina Plaz Torres et al. Journal of Clinical Medicine
- A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis
- (2021) Surender Singh et al. Journal of Clinical and Experimental Hepatology
- Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas
- (2021) Juan José Yepes-Nuñez et al. Revista española de cardiología (English ed.)
- Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis
- (2021) Makoto Chuma et al. HEPATOLOGY RESEARCH
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes
- (2020) David E. Kloecker et al. ANNALS OF INTERNAL MEDICINE
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The changing scenario of hepatocellular carcinoma in Italy: an update
- (2020) Francesca Garuti et al. LIVER INTERNATIONAL
- Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
- (2019) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study
- (2019) Tim A. Labeur et al. ONCOLOGIST
- Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
- (2018) Edoardo Giovanni Giannini et al. HEPATOLOGY
- Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis
- (2018) Mairéad Geraldine McNamara et al. EUROPEAN JOURNAL OF CANCER
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Prognosis of untreated hepatocellular carcinoma
- (2014) Edoardo G. Giannini et al. HEPATOLOGY
- BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group
- (2014) Fabio Farinati et al. LIVER INTERNATIONAL
- Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis
- (2012) T. Pressiani et al. ANNALS OF ONCOLOGY
- Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea
- (2010) Edoardo G. Giannini et al. LIVER INTERNATIONAL
- Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization
- (2009) Chia-Yang Hsu et al. LIVER INTERNATIONAL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started